| Market Cap | ₹2,928Cr |
| ROE | 0.85% |
| P/E Ratio(TTM) | 289.57 |
| EPS(TTM) | 0.82 |
| P/B Ratio | 2.45 |
| Dividend Yield | 0.34% |
| Industry P/E | 33.18 |
| Book Value | 96.86 |
| Debt to Equity | 0.57 |
| Face Value | 2 |
| Parent Organisation | Hikal Limited |
| Managing Director | Sameer Hiremath |
| Founded | 1988 |
| NSE Symbol | HIKAL |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Divi's Laboratories | NA (0.00%) | 68.16 | ||
| Neuland Laboratories | NA (0.00%) | 84.50 | ||
| Jubilant Pharmova | NA (0.00%) | 35.37 | ||
| Acutaas Chemicals | NA (0.00%) | 59.16 |